| ¿µ¹® | neoplasm | ÇÑ±Û | ½Å»ý¹° |
|---|---|---|---|
| ¼³¸í | »õ·Î »ý±ä ¹°ÁúÀ̶ó´Â ¶æÀÌ´Ù. À̰ÍÀº ´Ù¸¥ ¸»·Î ¡°Á¾¾ç(tumor)¡±À̶ó°íµµ ÇÏ´Â µ¥, ½ÇÁ¦·Î À̵éÀÇ ¸íÈ®ÇÑ ¶æÀº ¼·Î ´Ù¸£´Ù. Á¾¾çÀ̶ó´Â ¸»Àº ¡°±× Å©±â°¡ 1cm°¡ ³Ñ´Â ÀÏÁ¾ÀÇ È¤¡±À» ¸»ÇÏ´Â °ÍÀ¸·Î ÇǺΰú¿¡¼´Â À̺¸´Ù ÀÛÀº ȤÀ» ±¸ÁøÀ̶ó°í ÇÏ¿© ±¸º°ÇÏ¿© ºÎ¸¥´Ù. ÇÏÁö¸¸, À̰ÍÀº ¶ÇÇÑ ÇǺλӸ¸ ¾Æ´Ï¶ó ½Åü³» ¾îµð¿¡¼µç »ý±æ ¼ö ÀÖÀ¸¹Ç·Î ¸ðµÎ ÅëĪÇÏ¿© Á¾¾çÀ̶ó°í ºÎ¸¥´Ù. ÀÌ¿¡ ºñÇØ ¡°½Å»ý¹°¡±Àº ½Åü³» ¾ø´ø °ÍÀÌ »õ·Î »ý°Ü³µ´Ù´Â ¶æÀ¸·Î ºÙÀÎ ¸»ÀÌ´Ù. ±×·¯³ª, ÀÌ µÑÀÇ °ü°è¸¦ ¸íÈ®È÷ ±ÔÁ¤ÁþÁö ¾Ê°í ÀÖÀ¸¸ç ´ë°³ °°Àº ¶æÀ¸·Î È¥¿ëµÈ´Ù. ½Å»ý¹°¿¡´Â ¡°¾ç¼º(benign)¡±°ú ¡°¾Ç¼º(malignant)¡±ÀÌ ÀÖ´Ù. ÀÌ µÑÀÇ ±¸º°Àº ¿©·¯ °¡Áö ±âÁØ¿¡ µû¸£Áö¸¸, ¶§·Î´Â ±¸º°ÀÌ ¾î·Á¿ï ¶§µµ ÀÖ´Ù. ´ë°³ ¾ç¼ºÀº »ý¸í´ÜÃàÀ» Àß ÀÏÀ¸Å°Áö ¾Ê´Â °ÍÀ¸·Î Ä¡·áÈÄ¿¡ Àç¹ßµµ Àß ÇÏÁö ¾Ê´Â´Ù. ÀÌ¿¡ ºñÇØ ¾Ç¼ºÀº Àç¹ß»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ ±â°üÀ¸·Î ¿Å°Ü°¡¼ °°Àº º´º¯ÀÌ ¹ß»ýÇÏ´Â ¡°ÀüÀÌ(metastasis)¡±Çö»óµµ ÀϾÙ. µû¶ó¼ »ý¸íÀ» ´ÜÃà½ÃŰ´Â °æ¿ì°¡ ¸¹À¸¸ç, ´ë°³ Ä¡·á°¡ ¾î·Æ´Ù. |
||
| ¿µ¹® | malignant tumor | ÇÑ±Û | ¾Ç¼ºÁ¾¾ç |
|---|---|---|---|
| ¼³¸í | Á¤»óÀûÀÎ Á¶Á÷ ¼¼Æ÷°¡ °¢Á¾ ¹°¸®Àû-ÈÇÐÀû-»ý¹°ÇÐÀûÀÎ ¹ß¾Ï ¹°ÁúÀÇ ÀÛ¿ë ¶Ç´Â ¿äÀο¡ ÀÇÇØ µ¹¿¬º¯À̸¦ ÀÏÀ¸ÄѼ Çü¼ºµÇ´Â Á¾¾ç. ¹«Á¦ÇÑÀÇ ¼¼Æ÷ºÐ¿·Î ¸Å¿ì ¿Õ¼ºÇÏ°Ô Áõ½ÄÇÏ¿© ÁÖÀ§Á¶Á÷À» ÆÄ±«-ħ½ÄÇÑ´Ù. ¶Ç ¾î¶² ÈÇй°ÁúÀ» ³»¾î ÁÖÀ§ÀÇ Á¶Á÷¼¼Æ÷¸¦ Ä§ÇØÇÒ »Ó¸¸ ¾Æ´Ï¶ó, Ç÷°ü ¹× ¸²ÇÁ°üÀ» µû¶ó ÀüÀÌÇÏ¿© Àü½ÅÀÇ Ä«ÄʽþƸ¦ÀÏÀ¸ÄÑ Á×À½À» ÃÊ·¡ÇÑ´Ù. »óÇǼºÀÎ °ÍÀ» ¾ÏÁ¾À̶ó Çϰí, ºñ»óÇǼºÀÎ °ÍÀ» À°Á¾À̶ó ÇÑ´Ù. |
||
| ¿µ¹® | malignant melanoma | ÇÑ±Û | ¾Ç¼ºÈæ»öÁ¾ |
|---|---|---|---|
| ¼³¸í | ÇǺο¡¼ »ý±â´Â ¾ÏÀÇ ÀÏÁ¾. ÁÖ·Î ¹éÀο¡°Ô È£¹ßÇϸç, 50´ë~70´ë¿¡ ¸¹ÀÌ ¹ß»ýÇϰí, ÀþÀº ¿©¼º¿¡°Ô Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç, ÇǺξÏÁß 1~3%¸¦ Â÷ÁöÇÏ´Â µå¹® º´À¸·Î ÇÇºÎ¿Í ±âŸ ±â°üÀÇ ¸á¶ó´Ñ ¼¼Æ÷°è¿¡¼ À¯·¡ÇÏ´Â ¾Ç¼ºÁ¾¾çÀÌ´Ù. ¿øÀÎÀ¸·Î Àϱ¤³ëÃâ°ú Á÷Á¢ÀûÀÎ °ü°è°¡ ÀÖÀ¸¸ç °¡Á·Àû ¹ß»ýµµ º¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | kidney stones | ÇÑ±Û | ÄáÆÏµ¹, ÄáÆÏ°á¼® |
|---|---|---|---|
| ¼³¸í | ÄáÆÏÀÇ ±ò¶§±â ¶Ç´Â ¼úÀÜ¿¡ Çü¼ºµÈ µ¹À» ¸»ÇÏ¸ç ¿äÀú·ù, °¨¿°, ¿ä·® °¨¼Ò µîÀÌ ÀÖÀ» ¶§ Àß ³ªÅ¸³ª´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. Áõ»óÀº ¿·±¸¸®³ª Ãøº¹ºÎ¿¡ °©Àڱ⠻ý±â´Â ½ÉÇÑ µ¿Åë, À°¾ÈÀûÀ̳ª Çö¹Ì°æÀû Ç÷´¢, ôÃß°¥ºñ»À°¢ ¾ÐÅëÀÌ ÀÖÀ» ¼ö ÀÖÀ¸³ª °æ¿ì¿¡ µû¶ó Áõ»óÀÌ ¾øÀÌ ¿ì¿¬ÇÏ°Ô ¹ß°ßµÇ´Â ¼öµµ ÀÖ´Ù. Áø´ÜÀº ¿ä°Ë»ç³ª ¿ä¹è¾ç°Ë»ç, Ç÷¾×°Ë»ç, ¹æ»ç¼±°Ë»ç¸¦ ÀÌ¿ëÇØ¼ Çϸç Ä¡·á¹æÄ§Àº ±× µ¹ÀÇ È°¼ºµµ¿¡ µû¶ó ´Ù·®ÀÇ ¼öºÐ ¼·Ã볪 ÁøÅëÁ¦¸¦ »ç¿ëÇØ¼ ÀÚ¿¬¹èÃâÀ» À¯µµÇϰųª ü¿ÜÃæ°ÝÆÄ ¼â¼®¼ú, ³»ºñ´¢±â°úÀû ¼â¼®¼ú, ¼ö¼ú¿ä¹ý, ³»°úÀû ¿ä¹ýÀ» »ç¿ëÇÑ´Ù. µ¹ÀÇ È°¼ºµµ¶õ µ¿Åë, Æó»öÇö»ó, µ¹ÀÇ Å©±â Áõ°¡ ¿©ºÎ, »õ·Î¿î µ¹ÀÇ ¹ß»ý¿¡ ÀÇÇÏ¿© °áÁ¤µÇ¾îÁø´Ù. |
||
| ¿µ¹® | kidney | ÇÑ±Û | ÄáÆÏ, ½ÅÀå |
|---|---|---|---|
| ¼³¸í | Èĺ¹º®ÀÇ Á¦ 11µî»À¿¡¼ Á¦ 2Ç㸮»À ³ôÀÌÀÇ º¹¸· ¹Ù±ù¿¡ ÀÖ´Â °³¶Äá ÇüÅÂÀÇ Àå±â·Î¼ ¼¶À¯¼º ÇǸ·°ú Áö¹æ Á¶Á÷À¸·Î ½Î¿© ÀÖ´Ù. ¹«°Ô´Â ¾à 130gÀÌ¸ç ½ÇÁúÀº °ÑÁú°ú ¼ÓÁú·Î ³ª´µ¾î Áø´Ù. |
||
| MH | malignant histiocytosis; malignant hyperpyrexia; malignant hypertension; malignant hyperthermia; mam... |
|---|---|
| MRN | malignant renal neoplasm |
| MHS | major histocompatibility system; malignant hyperthermia in swine; malignant hyperthermia syndrome; m... |
| GTN | - Stages of GTN(FIGO, WHO) 1. Stage O; Molar Pregnancy(H-Mole... |
| FMN | first malignant neoplasm; flavin mononucleotide; frontomaxillonasal [suture] |
| SMN | Second Malignant Neoplasm |
|---|---|
| CMM | Cutaneous malignant melanoma |
| DMM | Desmoplastic Malignant Melanoma |
| IML | Intravascular malignant lymphomatosis |
| LMP | Low Malignant Potential |
| except | 1. To take or leave out (anything) from a number or a whole as not belonging to it; to exclude; to omit. "Who never touched The excepted tree." (Milton) "Wherein (if we only except the unfitness of the judge) all other things concurred." (Bp. Stillingfleet) 2. To object to; to protest against. Origin: L. Exceptus, p. P. Of excipere to take or draw out, to except; ex out + capere to take: cf. F. Excepter. See Capable. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| renal pelvis | <anatomy> The area at the centre of the kidney. Urine collects here and is funneled into the ureter. (12 Dec 1998) |
| kidney pelvis | The expansion from the upper end of the ureter into which the calices of the kidney (kidney calices) open. (12 Dec 1998) |
| antibodies, neoplasm | Immunoglobulins induced by antigens specific for tumours other than the normally occurring histocompatibility antigens. (12 Dec 1998) |
| antigens, neoplasm | Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumour cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. (12 Dec 1998) |
| brain neoplasm | Neoplasms of the part of the central nervous system contained within the cranium. (12 Dec 1998) |
| genes, structural, neoplasm | DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of neoplastic cells. (12 Dec 1998) |
| mucinous cystic neoplasm of pancreas | <radiology> = macrocystic adenoma of pancreas, cystadenoma / cystadenocarcinoma, M:F = 1:9, 40-60 years of age, malignant or pre-malignant, large mass (mean 12 cm), multilocular cysts, thick septations, tail / body in 85% (unlike adenocarcinoma and microcystic adenoma), hypo-/avascular, Differential diagnosis: panc pseudocyst, ** Cf: microcystic adenoma (12 Dec 1998) |
| histoid neoplasm | Old term for a neoplasm characterised by a cytohistologic pattern that closely resembles the tissue from which the neoplastic cells are derived. (05 Mar 2000) |
| neoplasm | <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous. (16 Dec 1997) |
| neoplasm circulating cells | Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumours. (12 Dec 1998) |
| neoplasm: gallium imaging | <radiology> Useful: Hodgkin disease and histiocytic form of NHL poor sensitivity below the diaphragm, Burkitt lymphoma: almost 100% sensitivity, hepatoma: 90% sensitivity, melanoma: 90% sensitivity, leukaemia possibly useful: NHL: good for large and mediastinal lesions, nodal metastases from seminoma and embryonal cell carcinoma: 87% sensitivity, non-small cell lung CA: 85% sensitive not useful: head and neck, GI (especially adenocarcinoma), breast, gynaecological, kiddie tumours see: gallium: indications (12 Dec 1998) |
| neoplasm invasiveness | Ability of neoplasms to infiltrate and actively destroy surrounding tissue. (12 Dec 1998) |
| neoplasm metastasis | The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms. (12 Dec 1998) |
| neoplasm recurrence, local | The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|